AcuCort Investor Relations Material
Latest events
Q2 2025
AcuCort
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from AcuCort
Access all reports
AcuCort is a biotechnology company that develops smart medicines for the treatment of chronic diseases, with a focus on pain. Their mission is to identify, develop and commercialize innovative products that meet the patient’s need for convenient and effective treatment.
Latest articles
)
American Express: An Empire of Plastic
How history, brand, and structure have steadily built American Express' moat, and why Warren Buffett still calls it a one-of-a-kind business.
19 Sep 2025
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
Ticker symbol
ACUC
Country
🇸🇪 Sweden